FDA Panel Endorses Onyx Pharmaceuticals' Blood Cancer Drug
A U.S. Food and Drug Administration advisory committee on Wednesday strongly recommended that the FDA approve Onyx Pharmaceuticals Inc.'s multiple myeloma drug carfilzomib, saying it looked forward to seeing results from...To view the full article, register now.
Already a subscriber? Click here to view full article